Fentanyl Injection Recalled for Lack of Sterility Assurance
SCA Pharmaceuticals recalls fentanyl 2,500 mcg/250 mL injection (548 bags) nationwide due to lack of assurance of sterility. The affected product may not meet pharmaceutical sterility standards required for injectable drugs.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable drug product where sterility assurance cannot be verified. Although no illnesses or injuries have been reported, the lack of sterility assurance in fentanyl injection represents a significant potential health risk.
Plain-English summary
SCA Pharmaceuticals is recalling fentanyl 2,500 mcg/250 mL in 0.9% Sodium Chloride Injection (10 mcg/mL) due to lack of assurance of sterility. A total of 548 bags have been distributed nationwide.
The affected product includes lot numbers 1223045757 (expiration 12/27/23) and 1223049716 (expiration 5/25/24). Sterility is a critical safety requirement for injectable drugs. These product batches may not meet pharmaceutical sterility standards.
Anyone with the affected lots should contact SCA Pharmaceuticals at 877.550.5059 or write to 755 Rainbow Road, Windsor, CT 06095.
The recalled product
- Product
- fentaNYL 2,500 mcg/250 mL in 0.9% Sodium Chloride Injection (Concentration = 10 mcg/mL), 250 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, 877.550.5059, NDC 70004-0229-40 BAR code 70004022940
- Manufacturer
- SCA Pharmaceuticals, LLC
- Category
- Drug — Injectable
- Hazard
- sterility-assurance
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 1223045757
- Exp 12/27/23
- 1223049716
- Exp 5/25/24
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27